Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Giese

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Therapeutic Drug Monitoring|September 30, 2015
Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin InhibitorsClaudia Sommerer, Thomas Giese
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2004
Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitorsThomas Giese, Martin Zeier, Stefan Meuer
Arzneimittel-Forschung|July 12, 2003
Functional characterization of pro-biotic pharmaceuticals by quantitative analysis of gene expressionThomas Giese, Kurt Zimmermann, Stefan C Meuer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2008
Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?Claudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Transplantation|May 14, 2010
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipientsClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|November 10, 2010
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipientsClaudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Approaches towards individualized immune interventionThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Clinical Nephrology|August 1, 2015
Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine AClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 2009
Monitoring immunosuppression with measures of NFAT decreases cancer incidenceThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Inflammatory Bowel Diseases|August 23, 2007
Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcriptsCarsten Schmidt, Winfried Häuser, Thomas Giese, et al.
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Therapeutic Drug Monitoring|September 30, 2015
Nuclear Factor of Activated T Cells-Regulated Gene Expression as Predictive Biomarker of Personal Response to Calcineurin InhibitorsClaudia Sommerer, Thomas Giese
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2004
Analysis of NFAT-regulated gene expression in vivo: a novel perspective for optimal individualized doses of calcineurin inhibitorsThomas Giese, Martin Zeier, Stefan Meuer
Arzneimittel-Forschung|July 12, 2003
Functional characterization of pro-biotic pharmaceuticals by quantitative analysis of gene expressionThomas Giese, Kurt Zimmermann, Stefan C Meuer
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2008
Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?Claudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Transplantation|May 14, 2010
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipientsClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|November 10, 2010
New concepts to individualize calcineurin inhibitor therapy in renal allograft recipientsClaudia Sommerer, Thomas Giese, Stefan Meuer, et al.
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Approaches towards individualized immune interventionThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Clinical Nephrology|August 1, 2015
Monitoring of calcineurin inhibitors by NFAT-regulated gene expression in de novo renal allograft recipients on cyclosporine AClaudia Sommerer, Martin Zeier, Stefan Meuer, et al.
Clinical Immunology (Orlando, Fla.)|April 29, 2009
Monitoring immunosuppression with measures of NFAT decreases cancer incidenceThomas Giese, Claudia Sommerer, Martin Zeier, et al.
Inflammatory Bowel Diseases|August 23, 2007
Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcriptsCarsten Schmidt, Winfried Häuser, Thomas Giese, et al.
Pageof 22